Back to Journals » Nursing: Research and Reviews » Volume 14
An Integrative Review of Opioid Stewardship: Optimizing Patient Care and Safety with a Multidisciplinary Approach
Authors Adams N , Ott CA , Mullen CJ, Wang Y
Received 1 December 2023
Accepted for publication 20 August 2024
Published 29 August 2024 Volume 2024:14 Pages 173—200
DOI https://doi.org/10.2147/NRR.S382437
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Dr Pariya Fazeli
Nicole Adams,1 Carol A Ott,2 Cody J Mullen,3 Yitong Wang4
1Purdue Regenstrief Center for Healthcare Engineering, West Lafayette, IN, USA; 2Purdue Department of Pharmacy Practice, West Lafayette, IN, USA; 3Purdue Department of Public Health, West Lafayette, IN, USA; 4Purdue School of Nursing, West Lafayette, IN, USA
Correspondence: Nicole Adams, Regenstrief Center for Healthcare Engineering, Purdue University, West Lafayette, IN, USA, 47907, Email [email protected]
Abstract: The opioid crisis in the United States continues to take the lives of tens of thousands of Americans each year. Opioid medications are important components of acute pain management and opioid stewardship is necessary to mitigate opioid misuse while providing adequate pain control for patients with severe medical needs. The definition of opioid stewardship includes the use of evidence-based guidelines, policies, and patient-centered practices to promote appropriate prescribing, use, and deprescribing of opioids to optimize treatment and minimize adverse consequences. There is little concrete guidance about how to achieve these goals or define the role and importance of various healthcare professionals in opioid stewardship programs. An integrative review process was used to evaluate and collate best practices in opioid stewardship from a variety of published papers. The integrative review was chosen to be inclusive of papers outside of quantitative research, allowing for interpretation of qualitative research, position statements, reports, editorials, and opinions. Data extraction included 71 publications that revealed common characteristics that can improve and coalesce opioid stewardship programs. Top characteristics and themes developed include prescribing guidelines, patient and provider education, referral and consultation, prescribing audits, barriers to opioid stewardship, the use of multidisciplinary teams and non-physician healthcare providers, accountability, risk of misuse, access to care, and patient-centeredness. The use of electronic health record tools, decision support tools, patient screening and discharge standards, and opioid tapering were recommended. Open and consistent communication between patients and healthcare providers is deemed essential. Staffing resources were found to be a significant barrier to opioid stewardship. This integrative review of publications related to opioid stewardship seeks to provide a comprehensive list of best practices that can be incorporated into programs to streamline processes and contribute to an organized foundation that can be used in research to illuminate practices that lead to enhanced outcomes.
Keywords: opioid, stewardship, multidisciplinary, education, patient-centered, barriers
Introduction
The opioid crisis in the US continues to take the lives of tens of thousands of Americans each year.1 According to the National Survey on Drug Use and Health, 8.9 million people aged 12 or older misused opioids in 2022. Of these, 8.5 million people misused prescription pain relievers. Among those diagnosed with a substance use disorder, less than 1% sought treatment owing to either believing that treatment was not needed or a lack of healthcare providers and treatment facilities.2 Data collated by the National Vital Statistics System counted more than 105,000 drug overdose deaths in the 12-month period ending October 2023 with approximately 70% of these deaths attributable to synthetic opioids.3 A paradox of these crises is that opioids are still important medications to manage pain, especially acute pain in the inpatient hospital setting.4 Healthcare professionals find themselves caught between trying to prevent opioid misuse and adequately controlling the pain of patients with severe medical needs. Professionals across disciplines are now called upon to be good stewards of opioids in their management of severe pain.
Stewardship is defined as “the careful and responsible management of something entrusted to one’s care”.5 Healthcare professionals are frequently called to be good stewards of resources which are limited in supply and interventions whose misuse can lead to negative consequences. Antimicrobial stewardship, or the judicious use of antibiotics, has been promoted since the late 1990s due to the rise in antibiotic resistant bacteria which is directly related to the overuse of antibiotics. Antimicrobial stewardship programs within healthcare settings provide guidance, monitoring, and feedback to prescribers so that they limit their use of antibiotics to only those situations which warrant them.6
Similarly, there has been a call for opioid stewardship programs to reduce the use of opioids to minimize the risk of harm from the misuse of opioids past their prescribed period while still managing pain effectively. Shrestha et al7 proposed a universal definition based on a systematic literature review which included 19 articles that defined opioid stewardship.
Opioid stewardship programs include evidence-based guidelines, policies, person-centered practices and research to promote rational prescribing, use and deprescribing of opioids for managing pain and specified health conditions. Opioid stewardship programmes should aim to optimise treatment by maximising clinical benefits for the patients and the wider society and minimising adverse consequences, including overuse, misuse, and diversion. Effective patient-provider communications and involving patients and/or their carers in decision-making are key to implementing any opioid stewardship program by considering evidence-based outcomes that matter to patients. Stewardship programmes should also focus on safe procurement, storage, and disposal practices. (Shrestha et al, 2023, p. 391)
Their definition strives to include the patient and shared decision-making to be as important as judicious prescribing practices.
As occurs with many definitions and policy guidance, this definition contains many statements about what stewardship programs should include, with little concrete guidance on how to achieve these goals and the role of different healthcare professionals in such a program. There is a lack of consensus regarding what constitutes opioid stewardship, as well as staffing patterns that do not allow time for opioid stewardship measures. A need exists for a wide-ranging accounting of what opioid stewardship entails to allow for more consistent development and implementation.
Our findings represent a comprehensive list of best practices which can be incorporated into opioid stewardship programs across the globe. This paper aims to provide the results of an integrative review of opioid stewardship practices to inform healthcare providers and institutions and form the basis for consistent and practical development and implementation of opioid stewardship.
Purpose
As noted, current opioid stewardship programs are often institution-specific and involve internally devised metrics that have not been standardized into clear objectives that constitute “opioid stewardship”. Interventions have focused primarily on prescribers and prescribing practices and less on non-prescribing healthcare providers and multidisciplinary teams. Patient assessments and education, as well as medication regimen histories and reviews that can be performed by nurses and pharmacists are less well-studied. To fill this gap, we sought to synthesize the literature promoting concepts of opioid safety and stewardship through the lens of multidisciplinary practice and patient care as defined by the literature. We focused on opioids in general rather than on specific conditions for which opioid may be prescribed, such as cancer or chronic pain, in order to develop broad concepts of opioid stewardship rather than the specific recommendations for prescribing for acute pain, chronic pain, or cancer pain.
Methods
We chose to conduct an integrative review to address opioid stewardship because this type of review allows for the inclusion of not only qualitative and quantitative research literature but also editorials, professional organization position papers and guidelines, reports, and quality improvement projects.8 This allows us the broadest view of stewardship practices from a multidisciplinary perspective and the identification of the most common characteristics and themes related to stewardship.
Literature Search
We began our literature search by asking the question: How are concepts of opioid stewardship focused on patient care and safety being used by healthcare professionals in their practice-specific roles (pharmacy, nursing, medicine) and in multidisciplinary healthcare teams? Using this question, we searched the following databases: Web of Science for “opioid stewardship”, and CINAHL, Academic All Search Complete, and PubMed for “opioid stewardship AND patient care”. We limited our search to the years 2013–2023. Our search approach and terms were developed in partnership with a medical librarian within the Purdue University Library system who influenced our decisions regarding search terms and databases.
We included publications from or about healthcare settings, opioid dispensing, prescribing, and administering, patient safety or patient care, nursing, pharmacy, and physician activities. We included research publications as well as position statements and guidelines from professional organizations, reports, and editorial or opinion pieces across the globe if published in English. We excluded publications that were outside of healthcare settings including dentistry, non-professional administration of opioids, and papers published before 2013.
Our search returned 286 publications which were uploaded to Covidence for evaluation. Covidence is an online software platform that is used to manage literature reviews by research teams. There were 89 duplicate articles removed identified in multiple searched databases and an additional 76 studies were removed during screening due to the team determining they were irrelevant based on team consensus. Of the 114 full-text manuscripts reviewed, an additional 43 studies were excluded by team consensus, primarily because they reported solely on descriptive studies of opioid prescribing without any inclusion of stewardship practices or interventions. Data extraction was conducted by group consensus on 71 publications. Two reviewers independently reviewed each publication using a template described below. Not all fields applied to all publications reviewed. At each stage of the review process, two reviewers independently reviewed and made an assessment. Covidence indicated if there was a difference in assessment and a third author reviewed with the initial two who completed the review. The publication selection can be seen in the PRISMA flow diagram in Figure 1.
![]() |
Figure 1 PRISMA flow diagram for review of characteristics associated with opioid stewardship. |
Data Extraction
A template was created in Covidence to standardize the data extraction process. This template included the title of the paper, country in which the study was conducted, notes from the reviewer, aim of the study, study design, population description, exclusion criteria, total number of participants, population characteristics, population characteristic percentage if applicable, study findings, up to 25 opioid stewardship characteristics, up to five positive themes, and up to five negative themes. This allowed for both quantitative and qualitative data to be extracted from both research publications and other types of literature such as editorials. Themes may have been findings from qualitative studies or conclusions of opinion pieces which did not fit the description of an opioid stewardship characteristic. An example of a positive theme from an opinion piece would be having an organizational focus on opioid stewardship. Data was extracted from each paper by 2 team members independently and then consensus between the extractions was conducted by a third team member. A summary of the papers included in the data extraction is presented in Table 1.
![]() |
Table 1 Description of Components of Included Publications |
Data Analysis
The extracted data was exported from Covidence into Microsoft Excel spreadsheets for analysis. In total there were 708 characteristics of stewardship identified and 89 qualitative themes extracted from the 71 papers. To better manage the data, each characteristic was assigned a descriptive code with some characteristics assigned sub-topic. For example, the characteristic “assessing patient risk factors for respiratory depression” was coded as “adverse effects” with sub-topic “respiratory”. Similarly, each theme was assigned codes and sub-topics. Coding was validated by the team through consensus.
Findings
Many of the papers were about systems and research conducted in the United States, followed by Canada and Australia. Most of the papers were opinion pieces, followed by quality improvement and cross-sectional studies. There was only one randomized controlled trial and one non-randomized experimental trial. The characteristics are presented in Table 2.
![]() |
Table 2 World Geographic Region and Publication Classification |
There were a total of 58 characteristic codes and 70 sub-topics assigned to the characteristics. Table 3 illustrates each of the characteristics and the sub-topics within each characteristic. The top five characteristics were prescribing guidelines (103 manuscripts), patient education (71 manuscripts), refer/consult (45 manuscripts), audit of prescribing (42 manuscripts), and provider education (42 manuscripts). There were 34 characteristics that were mentioned in five or fewer manuscripts. To get another view of the data, the sub-topics were used as headings to assess their frequency. Table 4 shows the distribution of sub-topics and characteristics associated with each with frequency. The most common sub-topic was care plan and goals (32 manuscripts), followed by pain management (27 manuscripts), assessment (20 manuscripts), and prescribing (18 manuscripts). The most common characteristic associated with care plan and goals was patient education (23 manuscripts).
![]() |
Table 3 Opioid Stewardship Characteristic Codes and Sub-Topics |
![]() |
Table 4 Opioid Stewardship Characteristic Coding and Sub-Topics |
There were a total of 98 themes extracted from the literature. There was a broad variety in the themes which could only be reduced to 39 theme codes and 22 sub-topics. The top seven codes had 4 or more themes assigned to them and can be seen in Table 5 with their sub-topics. The most common theme was barriers identified that inhibited opioid stewardship (12 manuscripts), followed by team (8 manuscripts), education (5 manuscripts), accountability (4 manuscripts), patient-centered (4 manuscripts), risk and access (4 manuscripts). The most common sub-topic for barriers to opioid stewardship was a lack of staff followed by insurance.
![]() |
Table 5 Most Common Themes in Opioid Stewardship |
Discussion
By far, the most common characteristic of opioid stewardship was related to prescribing guidelines, with the most common sub-topic of setting limits on prescribing. Also, common was titrating opioid doses to establish the lowest dose needed for effective pain management. This intervention is primarily targeted towards physicians and other advanced practice providers who order medications and write prescriptions. The next most common feature of opioid stewardship is patient education, and the most common sub-topics are related to care planning and goal setting, general patient education, and disposal of opioids. However, we also see education as a sub-topic of both the pharmacist and nurse role and a multidisciplinary approach begins to appear. The next six most common characteristics all similarly relate to the prescriber. Not until the 7th most common characteristic do we see a multidisciplinary approach that includes the role of the pharmacist as a significant characteristic of opioid stewardship. We found many position papers and guidelines created by professional pharmacy practice organizations. Pharmacists have a unique role in healthcare as guardians and gatekeepers of medications, so it is logical that they would lead opioid stewardship initiatives. Their advanced knowledge of medications makes them ideal to provide education to providers and patients alike. There is also mention of their interaction with nurses and patients as part of care planning. Further down the list of characteristics, non-pharmacological pain management appears as the 13th most commonly mentioned. This is a pain management strategy that can be delivered by a wide variety of healthcare workers80 and has long been part of nursing practice.81 As providers continue to reduce their use of opioid medications, nurses will need to augment analgesics with non-pharmacological pain management techniques.
Knowing the patient and providing appropriate patient education about expectations for treatment with opioid prescriptions has been noted to be a common feature of opioid stewardship. Recommendations for patient education included broad pain management for which opioid medications may be a part, a limited number of opioid doses per prescription, and expectations for refills. Pain contracts and care plan goals were also sub-topics in patient education. Disposal of unused opioid medications is also a part of patient education. Further sub-topics related to disposal include safe storage and the use of medication take-back programs.
Provider education about pain management treatment guidelines and the auditing of prescribing practices were common characteristics found in opioid stewardship programs. Published papers that studied the impact of provider education on opioid prescribing generally found that audits of prescribing practices led to decreases in opioid prescriptions and the number of morphine milliequivalents (MMEs) per prescription for a short duration but did not often produce longer-lasting results indicating that routine audits and continuing education are likely needed.
Patient screening for a history of or current substance misuse was a consistently recommended characteristic of opioid stewardship. Mental health assessment and treatment were strategies mentioned to provide optimal patient-centered care and pain management. Chronic pain should be addressed as a part of patient assessment and patient education. The role of pharmacists and nurses in patient and provider education, as well as patient screening, was highlighted.
Other top strategies include the need for open and consistent communication between patients and healthcare providers, committees to oversee stewardship, electronic tools to assist in decision support, patient discharge standards, the use of naloxone (Narcan), awareness of adverse effects, tapering opioids, awareness of morphine equivalents, and drug screening. There were only four mentions of teams or interprofessional collaboration presented as a characteristic of opioid stewardship. This is notable because in the assessment of qualitative themes, teams were the second most frequently mentioned concept, following barriers to successful implementation of stewardship programs in importance. Having adequate resources, including staff, appears to be the biggest barrier to successful opioid stewardship.
There is a key role for healthcare administration and clinical leadership to ensure the development of a culture of opioid stewardship amongst all members of the care team and stronger cross-discipline collaboration and teamwork in patient care. Team-based care is an important aspect as healthcare transfers into its new era of accountability through stewardship of prescribing opioids but also antibiotics and other medications.
Developing and implementing an opioid stewardship program can be challenging when faced with a myriad of possible metrics, a lack of staffing and resources, limited availability of substance use disorder treatment programs and healthcare provider bias related to substance use disorder. Funding streams for employee positions can be evaluated to allocate toward a healthcare provider who is specifically tasked with creating and leading a multidisciplinary team for opioid stewardship. In many institutions, this position is held by a nurse or pharmacist. A member of administration can champion this position and provide support and oversight. Educational objectives for healthcare providers of all disciplines should include modules on bias and stigma in addition to evidence-based opioid prescribing and monitoring practices.
Limitations
There are limitations to this review. This review may not include every publication related to opioid stewardship; however, we did see repetition in characteristics and themes suggesting data saturation. The inclusion of additional manuscripts is unlikely to alter our findings and recommendations. We chose to focus on general opioid stewardship rather than disease-specific opioid management strategies and therefore did not contrast the use of opioids for acute pain to those used for cancer or chronic pain. By design, the integrative review includes a broad variety of literature, and the quality of the literature was not assessed or used as a limitation to inclusion and it allowed us to include 22 opinion or editorial pieces, 2 guidelines, and 2 reports which appear in searches but are not peer-reviewed. We did not conduct a meta-analysis of the quantitative studies, which may have found that different characteristics of stewardship are more effective in the management and appropriate use of opioids than those that are most commonly listed. We took a quasi-qualitative approach to data analysis and although we attempted to improve rigor through consensus and independent reviews, individual bias may have affected our coding and results. Related to the content of the reviewed literature, the primary focus of current literature is on prescribers and prescribing practices with less study of the role and impact of non-prescribing healthcare professionals in opioid stewardship. Patient education about the risks of opioid misuse and expectations of opioid drug therapy, as well as screening for a history of substance misuse, is discussed but more research is needed in this area to further elevate the unique expertise of nurses and pharmacists in these areas. Exploration into the contribution of other providers, including social workers and peer recovery support specialists, is lacking and would benefit from enquiry. Research into the creation of true multidisciplinary teams that include prescribers, pharmacists, nurses, social workers, and case managers with delineation of roles and evaluation of patient outcome metrics can contribute to the evidence base. The most effective content of educational programming for prescribers and other healthcare providers is not well-studied. Findings of this review suggest that education specific to prescribing practices is helpful to apply evidence-based practices for a period of time but adherence wanes. Supplementary education that delves into personal bias, patient experiences of substance use disorder and needs in treatment, and the effectiveness of alternative forms of pain management is absent. Research into the development and delivery, as well as effectiveness of this type of education would be beneficial. This integrative review is intended to be broad in nature and discuss the current state of opioid stewardship metrics, as such, it is generalizable to wide range of institutions and healthcare providers. Editorials and opinion pieces were included in this review which may impact the applicability of the findings to specific institutions.
Conclusion
Although the concept of multidisciplinary patient care is broadly accepted, we found that the literature identifying opioid stewardship practices is heavily weighted towards the role of the prescriber. Current intervention development to improve opioid stewardship which should focus on prescribers is needed. The role of the pharmacists, nurses, and other allied health professionals must be incorporated into opioid stewardship programs as we focus on addressing opioid misuse. We believe additional research into the role of non-prescribing healthcare workers in effective pain management and opioid stewardship programs is still needed to establish true best practices. Further review of non-prescribing allied health professionals in a multi-disciplinary approach is needed as well as potential intervention design in training and practice to increase their holistic involvement in opioid stewardship.
Patient-centered care is a theme of opioid stewardship that was consistently noted throughout this review. Provider education that encompasses patient communication related to patient expectations and comfort with pain management was an important feature of opioid stewardship but outcomes of this standard as a best practice are not found in current literature. We believe this research would be an important addition to our current knowledge.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Centers for Disease Control and Prevention (CDC). Drug Overdose Deaths. Drug Overdose. 2023.
2. Substance Abuse and Mental Health Services Administration(SAMHSA). Key Substance Use and Mental Health Indicators in the United States: results from the 2022 National Survey on Drug Use and Health. 2023; Available From: https://www.samhsa.gov/data/.
3. Centers for Disease Control and Prevention (CDC). Provisional Drug Overdose Death Counts. National Center for Vital Statistics2024; Available From: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
4. Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the safety of opioid use for acute noncancer pain in hospitalized adults: a consensus statement from the society of hospital medicine. J Hosp Med. 2018;13(4):263–271. doi:10.12788/jhm.2980
5. Merriam-Webster. Stewardship. 2023; available from: https://www.merriam-webster.com/dictionary/stewardship.
6. Centers for Disease Control and Prevention (CDC). Core Elements of Hospital Antibiotic Stewardship Programs. Antibiotic Pres Use. 2023.
7. Shrestha S, Khatiwada AP, Sapkota BSS, et al. What is “Opioid Stewardship”? An Overview of Current Definitions and Proposal for a Universally Acceptable Definition. J Pain Res. 2023;16(1):383–394. doi:10.2147/JPR.S389358
8. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–553. doi:10.1111/j.1365-2648.2005.03621.x
9. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022;71(3):1–95. doi:10.15585/mmwr.rr7103a1
10. Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving Beyond Misuse and Diversion: the Urgent Need to Consider the Role of Iatrogenic Addiction in the Current Opioid Epidemic. Am J Public Health. 2014;104(11):2023–2029. doi:10.2105/AJPH.2014.302147
11. Ghafoor VL, Phelps P, Pastor J. Implementation of a pain medication stewardship program. Am J Heal Pharm. 2013;70(23):2070–2075.
12. Gross J, Gordon DB. The Strengths and Weaknesses of Current US Policy to Address Pain. Am J Public Health. 2019;109(1):66–72. doi:10.2105/AJPH.2018.304746
13. Kim B, Nolan S, Beaulieu T, Shalansky S, Ti L. Inappropriate opioid prescribing practices: a narrative review. Am J Heal Pharm. 2019;76(16):1231–1237.
14. Bicket MC, Brat GA, Hutfless S, Wu CL, Nesbit SA, Alexander GC. Optimizing opioid prescribing and pain treatment for surgery: review and conceptual framework. Am J Heal Pharm. 2019;76(18):1403–1412.
15. Patanwala AE. When less is more: opioid use in the emergency department. Am J Heal Pharm. 2019;76(22):1812–1813.
16. Behar E, Bagnulo R, Knight K, Santos GM, Coffin PO. “Chasing the pain relief, not the high”: experiences managing pain after opioid reductions among patients with HIV and a history of substance use. PLoS One. 2020;15(3):1–16.
17. Kennedy MC, Pallotti P, Dickinson R, Harley C. “If you can’t see a dilemma in this situation you should probably regard it as a warning”: a metasynthesis and theoretical modelling of general practitioners’ opioid prescription experiences in primary care. Br J Pain. 2019;13(3):159–176. doi:10.1177/2049463718804572
18. Executive summary of the meeting of the 2018 ASHP Commission on Goals: Focus on Opioids. Am J Health Syst Pharm. 76:187–191.
19. Homsted FAE, Magee CE, Nesin N. Population health management in a small health system: impact of controlled substance stewardship in a patient-centered medical home. Am J Heal Pharm. 2017;74(18):1468–1475.
20. Sundararajan K, Ajrawat P, Canizares M, et al. The potential for diversion of prescribed opioids among orthopaedic patients: results of an anonymous patient survey. PLoS One. 2021;16:1–13.
21. Clarke HA, Manoo V, Pearsall EA, et al. Consensus Statement for the Prescription of Pain Medication at Discharge after Elective Adult Surgery. Can J Pain. 2020;4:67–85. doi:10.1080/24740527.2020.1724775
22. Coffin PO, Rowe C, Oman N, et al. Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain. PLoS One. 2020;15:1–14.
23. Hoffman JM, Evans WE. Public policy imperatives to improve medication use. Am J Heal Pharm. 2018;75:49–51.
24. Poirier RH, Brown CS, Baggenstos YT, et al. Impact of a pharmacist-directed pain management service on inpatient opioid use, pain control, and patient safety. Am J Heal Pharm. 2019;76:17–25.
25. Rodrigue D, Winkelmann J, Price M, Kalandranis E, Klempner L, Kapoor-Hintzen N. Opioid Misuse: an organizational response while managing cancer-related pain. Clin J Oncol Nurs. 2020;24:170–176. doi:10.1188/20.CJON.170-176
26. Macintyre PE. The opioid epidemic from the acute care hospital front line. Anaesth Intensive Care. 2022;50:29–43. doi:10.1177/0310057X211018211
27. McEwen V, Esterlis M, Lorello GR, Sud A, Englesakis MF, Bhatia A. A scoping review of gaps identified by primary care providers in caring for patients with chronic non-cancer pain. Can J Pain. 2022:1.
28. Zhao J, Salemohamed N, Stinson J, et al. Health care providers’ experiences and perceptions participating in a chronic pain telementoring education program: a qualitative study. Can J Pain. 2020;4:111–121. doi:10.1080/24740527.2020.1749003
29. Pacheco S, Nguyen LMT, Halphen JM, et al. Adherence to Opioid Patient Prescriber Agreements at a Safety Net Hospital. Cancers. 2023;15(11):2943. doi:10.3390/cancers15112943
30. Burgart AM, Char D. The opioid crisis should lead pediatric anesthesiologists to a broader vision of opioid stewardship. Pediatr Anesth. 2019;29(11):1078–1080.
31. Villwock JA, Villwock MR, New J, Ator GA. EMR quantity autopopulation removal on hospital discharge prescribing patterns: implications for opioid stewardship. J Clin Pharm Ther. 2020;45(1):160–168.
32. Report of the ASHP Opioid Task Force. Am J Heal Pharm. 2020;77(14):1158–1165.
33. Poulin PA, Shergill Y, Grebowicz A, et al. Extension for community Healthcare Outcomes (ECHO) chronic pain & opioid stewardship in northwestern Ontario: a thematic analysis of patient cases. Can J Pain. 2022;6(1):211–224. doi:10.1080/24740527.2022.2126754
34. Thomas C, Ayres M, Pye K, Yassin D, Howell SJ, Alderson S. Process, structural, and outcome quality indicators to support perioperative opioid stewardship: a rapid review. Perioper Med. 2023;12(1):1–13.
35. Reed K. Sustainable access to appropriate opioids for palliative care patients in Australia-preventing the need for crisis management. J Pain Palliat Care Pharmacother. 2020;34(1):13–21. doi:10.1080/15360288.2019.1650869
36. Ramwani RJ, Wernberg JA. The Use of Opioid Analgesia after Surgery: assessing Postoperative Prescriptions from a Patient and Surgeon Perspective. Clin Med Res. 2022;20(2):89–94. doi:10.3121/cmr.2021.1630
37. Gondora N, Versteeg SG, Carter C, et al. The role of pharmacists in opioid stewardship: a scoping review. Res Soc Adm Pharm. 2022;18(5):2714–2747. doi:10.1016/j.sapharm.2021.06.018
38. Holloway GL, Weymiller AJ, Allemand A. Goal-Directed Opioid Stewardship in Acute-on-Chronic Nonmalignant Pain Management. J Nurse Pract. 2022;18(6):649–652. doi:10.1016/j.nurpra.2022.03.008
39. Hemmann BM, Moore PS, Politis PA, Frate DM. A Quality Improvement Pilot of Pharmacist-Led Identification of an Inpatient Population for Opioid Stewardship and Pain Management. J Pain Palliat Care Pharmacother. 2021;35(2):77–83. doi:10.1080/15360288.2021.1883181
40. Edelman LS, Hemmert R. Opioid Use in Long-Term Care: guidelines and Policy Recommendations. J Gerontol Nurs. 2019;45(9):5–10. doi:10.3928/00989134-20190813-02
41. Hyland SJ, Wetshtein AM, Grable SJ, Jackson MP. Acute Pain Management Pearls: a Focused Review for the Hospital Clinician. Healthc. 2022;11(1). doi:10.3390/healthcare11010034
42. Odom-Forren J, Brady J, Sloan PA. Perianesthesia Patient Education for the Promotion of Opioid Stewardship. J Perianesth Nurs. 2021;36(2):108–115. doi:10.1016/j.jopan.2020.06.012
43. Varley PR, Zuckerbraun BS. Opioid Stewardship and the Surgeon. JAMA Surg. 2018;153(2):e174875. doi:10.1001/jamasurg.2017.4875
44. Hood A, Hemmann B, Chae S. Survey of Opioid Stewardship Practices in American Society of Health-System Pharmacists (ASHP) Post-Graduate Year 2 (PGY2) Pain Management and Palliative Care (PMPC) Pharmacy Residency Programs. J Pain Palliat Care Pharmacother. 2021;35(2):73–76. doi:10.1080/15360288.2021.1914282
45. Clifford T. Opioid Stewardship. J Perianesth Nurs. 2017;32(4):377–378. doi:10.1016/j.jopan.2017.05.002
46. Lu E, Schell JO, Koncicki HM. Opioid Management in CKD. Am J Kidney Dis. 2021;77(5):786–795. doi:10.1053/j.ajkd.2020.08.018
47. Bui T, Bortz H, Cairns KA, et al. AAA stewardship: managing high‐risk medications with dedicated antimicrobial, anticoagulation and analgesic stewardship programs. J Pharm Pr Res. 2021;51(4):342–347. doi:10.1002/jppr.1716
48. Barrett TW, McEvoy MD, Fowler LC, et al. Impact of an Asynchronous Spaced Education Learning Intervention on Emergency Medicine Clinician Opioid Prescribing. Cureus. 2021. doi:10.7759/cureus.18165
49. Auffenberg G, Smith AB, Averch TD, et al. Opioid Stewardship in Urology: quality Improvement Summit 2018. Urol Pract. 2020;7(5):349–355. doi:10.1097/UPJ.0000000000000113
50. Ardeljan LD, Waldfogel JM, Bicket MC, et al. Current state of opioid stewardship. Am J Heal Pharm. 2020;77(8):636–643. doi:10.1093/ajhp/zxaa027
51. Allen ML, Leslie K, Parker AV, et al. Post-surgical opioid stewardship programs across Australia and New Zealand: current situation and future directions. Anaesth Intensive Care. 2019;47(6):548–552. doi:10.1177/0310057X19880904
52. Xu K, Nolan S, Mihic T, Ti L. Improving opioid stewardship programs through shared decision-making. J Am Pharm Assoc. 2022;62(3):697–700. doi:10.1016/j.japh.2022.02.001
53. Woods B, Legal M, Shalansky S, Mihic T, Ma W. Designing a pharmacist opioid safety and intervention tool. Can J Hosp Pharm. 2020;73(1):7–12. doi:10.4212/CJHP.V73I1.2952
54. A Health System – wide Initiative to Decrease Opioid-Related Morbidity and Mortality.
55. Tilli T, Hunchuck J, Dewhurst N, Kiran T. Opioid stewardship: implementing a proactive, pharmacist-led intervention for patients coprescribed opioids and benzodiazepines at an urban academic primary care centre. BMJ Open Qual. 2020;9(2):e000635. doi:10.1136/bmjoq-2019-000635
56. Ternel (Lebret) SC. Considerations for perioperative opioid analgesic stewardship in Australia: a focus on tapentadol. Pain Manag. 2023. doi:10.2217/pmt-2022-0103
57. Shoemaker-Hunt SJ, Wyant BE. The Effect of Opioid Stewardship Interventions on Key Outcomes: a Systematic Review. J Patient Saf. 2020;16(3):S36–S41. doi:10.1097/PTS.0000000000000710
58. Shah P, Siu A. Considerations for neonatal and pediatric pain management. Am J Heal Pharm. 2019;76(19):1511–1520. doi:10.1093/ajhp/zxz166
59. Sangal RB, Rothenberg C, Hawk K, et al. Real-World Observational Evaluation of Common Interventions to Reduce Emergency Department Prescribing of Opioid Medications. Jt Comm J Qual Patient Saf. 2023;49(5):239–246. doi:10.1016/j.jcjq.2023.01.013
60. Sandbrink F, Oliva EM, McMullen TL, et al. Opioid Prescribing and Opioid Risk Mitigation Strategies in the Veterans Health Administration. J Gen Intern Med. 2020;35:927–934. doi:10.1007/s11606-020-06258-3
61. Sandbrink F, Uppal R. The Time for Opioid Stewardship Is Now. Jt Comm J Qual Patient Saf. 2019;45(1):1–2. doi:10.1016/j.jcjq.2018.10.004
62. Rizk E, Yuan F, Zheng F, et al. Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgery. Otolaryngol Head Neck Surg. 2022. doi:10.1177/01945998221121626
63. Rizk E, Swan JT. Development, validation, and assessment of clinical impact of real-time alerts to detect inpatient as-needed opioid orders with duplicate indications: prospective study. J Med Internet Res. 2021;23(10):1–8. doi:10.2196/28235
64. Poteryko S, Nolan S, Mihic T, Ti L. Moving Away From a “One Size Fits All” Model: ensuring Opioid Stewardship Includes People Who Use Drugs. J Addict Med. 2022;16(4):386–388. doi:10.1097/ADM.0000000000000938
65. Pedersen CA, Schneider PJ, Ganio MC, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing—2019. Am J Heal Pharm. 2020;77(13):1026–1050. doi:10.1093/ajhp/zxaa104
66. Pattullo C, Suckling B, Donovan P, Hall L. Developing a framework for implementing opioid stewardship programmes in Australian hospital settings. Intern Med J. 2022;52(4):530–541. doi:10.1111/imj.15555
67. Pattullo C, Suckling B, Taylor S, et al. Developing and piloting an adaptable oxycodone quality improvement strategy: steps towards opioid stewardship. Aust Heal Rev. 2021;45(3):353–360. doi:10.1071/AH20262
68. Ordies S, Rex S. Intraoperative opioids: reduce but not refuse! Acta Anaesthesiol Belg. 2023;74(1):3–6. doi:10.56126/74.1.02
69. Mittal S, Shukla AR, Sahadev R, et al. Reducing post-operative opioids in children undergoing outpatient urologic surgery: a quality improvement initiative. J Pediatr Urol. 2020;16(6):
70. Kline TV, Savage RL, Greenslade JH, Lock CL, Pattullo C, Bell AJ. Affecting emergency department oxycodone discharge prescribing: an educational intervention. EMA Emerg Med Australas. 2019;31(4):580–586. doi:10.1111/1742-6723.13261
71. Jordan M, Young-Whitford M, Mullan J, Stewart A, Chen TF. A pharmacist-led intervention to improve the management of opioids in a general practice: a qualitative evaluation of participant interviews. Int J Clin Pharm. 2022;44(1):235–246. doi:10.1007/s11096-021-01340-0
72. Hopkins RE, Bui T, Konstantatos AH, et al. Educating junior doctors and pharmacists to reduce discharge prescribing of opioids for surgical patients: a cluster randomised controlled trial. Med J Aust. 2020;213(9):417–423. doi:10.5694/mja2.50812
73. Haq N, McMahan VM, Torres A, et al. Race, pain, and opioids among patients with chronic pain in a safety-net health system. Drug Alcohol Depend. 2021;222:108671. doi:10.1016/j.drugalcdep.2021.108671
74. Ghafoor VL, Phelps PK, Pastor J, Meisel S. Transformation of Hospital Pharmacist Opioid Stewardship. Hosp Pharm. 2019;54(4):266–273. doi:10.1177/0018578718809267
75. Forget P, Patullo C, Hill D, et al. System-level policies on appropriate opioid use, a multi-stakeholder consensus. BMC Health Serv Res. 2022;22(1):329. doi:10.1186/s12913-022-07696-x
76. Dowd LA, Cross AJ, Liau SJ, et al. Identifying Residents Who May Benefit from an Analgesic Review: applying Analgesic Indicators in Residential Aged Care Services. Drugs Aging. 2023;40(5):449–459. doi:10.1007/s40266-023-01025-5
77. DiScala S, Uritsky TJ, Brown ME, Abel SM, Humbert NT, Naidu D. Society of Pain and Palliative Care Pharmacists White Paper on the Role of Opioid Stewardship Pharmacists. J Pain Palliat Care Pharmacother. 2023;37(1):3–15. doi:10.1080/15360288.2022.2149670
78. DeUgarte DA, Fleischman R, Mccollough M, Ault G, Rolfe K, De Virgilio C. Assessment of an Opioid Stewardship Program on Perioperative Opioid Prescribing in a Safety-Net Health System. JAMA Surg. 2023;158(3):318. doi:10.1001/jamasurg.2022.4499
79. Chen A, Legal M, Shalansky S, Mihic T, Su V. Evaluating a Pharmacist-Led Opioid Stewardship Initiative at an Urban Teaching Hospital. CJHP. 2021;74(3). doi:10.4212/cjhp.v74i3.3152
80. Pollack SW, Skillman SM, Frogner BK. The Health Workforce Delivering Evidence-Based Non-Pharmacological Pain Management. FamilymedicineUwEdu. 2020;(2):1–22.
81. Lewis MJM, Kohtz C, Emmerling S, Fisher M, Mcgarvey J. Pain control and nonpharmacologic interventions. Nursing2023. 2018;48(9).
© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles
Analyzing Trends in the Pain Fellowship Match – A Survey of Program Directors
Jueng J, Pritzlaff SG, Mehta N, Gulati A, Schatman ME, Wahezi SE, Day M, Durbhakula S, Pak DJ
Journal of Pain Research 2025, 18:2335-2341
Published Date: 7 May 2025